SE9801288D0 - Vaccine delivery system and metod of production - Google Patents
Vaccine delivery system and metod of productionInfo
- Publication number
- SE9801288D0 SE9801288D0 SE9801288A SE9801288A SE9801288D0 SE 9801288 D0 SE9801288 D0 SE 9801288D0 SE 9801288 A SE9801288 A SE 9801288A SE 9801288 A SE9801288 A SE 9801288A SE 9801288 D0 SE9801288 D0 SE 9801288D0
- Authority
- SE
- Sweden
- Prior art keywords
- delivery system
- vaccine
- vaccine delivery
- polymer particle
- production
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/04—Solvent extraction of solutions which are liquid
- B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
- B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801288A SE9801288D0 (sv) | 1998-04-14 | 1998-04-14 | Vaccine delivery system and metod of production |
AU40662/99A AU765118B2 (en) | 1998-04-14 | 1999-04-09 | Polymer particle vaccine delivery system |
US09/308,435 US6838089B1 (en) | 1998-04-14 | 1999-04-09 | Antigen delivery system and method of production |
JP2000543160A JP4759134B2 (ja) | 1998-04-14 | 1999-04-09 | ポリマー粒子ワクチンデリバリーシステム |
AT99924075T ATE545432T1 (de) | 1998-04-14 | 1999-04-09 | Abgabevorrichtung für impfstoff auf basis von polymerpartikeln |
EP99924075A EP1071457B1 (en) | 1998-04-14 | 1999-04-09 | Polymer particle vaccine delivery system |
PCT/SE1999/000582 WO1999052550A1 (en) | 1998-04-14 | 1999-04-09 | Polymer particle vaccine delivery system |
JP2011001576A JP2011140491A (ja) | 1998-04-14 | 2011-01-07 | ポリマー粒子ワクチンデリバリーシステム |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801288A SE9801288D0 (sv) | 1998-04-14 | 1998-04-14 | Vaccine delivery system and metod of production |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9801288D0 true SE9801288D0 (sv) | 1998-04-14 |
Family
ID=20410947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9801288A SE9801288D0 (sv) | 1998-04-14 | 1998-04-14 | Vaccine delivery system and metod of production |
Country Status (7)
Country | Link |
---|---|
US (1) | US6838089B1 (xx) |
EP (1) | EP1071457B1 (xx) |
JP (2) | JP4759134B2 (xx) |
AT (1) | ATE545432T1 (xx) |
AU (1) | AU765118B2 (xx) |
SE (1) | SE9801288D0 (xx) |
WO (1) | WO1999052550A1 (xx) |
Families Citing this family (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6264991B1 (en) * | 1998-08-18 | 2001-07-24 | Southern Research Institute | Compositions and methods for treating intracellular infections |
AU7247000A (en) * | 2000-01-11 | 2001-07-19 | Givaudan Sa | Composite materials |
GB0010371D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
GB0027357D0 (en) | 2000-11-09 | 2000-12-27 | Bradford Particle Design Plc | Particle formation methods and their products |
EP1417236A4 (en) * | 2001-07-10 | 2010-03-17 | Corixa Corp | COMPOSITIONS AND METHODS FOR ADMINISTRATION OF ENCAPSULATED PROTEINS AND ADJUVANTS IN MICROSPHERES |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
JP2006525303A (ja) | 2003-05-08 | 2006-11-09 | ネクター セラピューティクス ユーケー リミティド | 微粒子物質 |
US20060263350A1 (en) * | 2003-09-26 | 2006-11-23 | Fairfield Clinical Trials Llc | Combination antihistamine medication |
SI21639A (sl) * | 2003-12-23 | 2005-06-30 | LEK farmacevtska dru�ba d.d. | Farmacevtski pripravek, ki vsebuje nemicelarne sulfobetaine |
CA2571899A1 (en) * | 2004-07-01 | 2006-08-03 | Yale University | Targeted and high density drug loaded polymeric materials |
US8071382B2 (en) * | 2004-12-22 | 2011-12-06 | Kyungpook National University Industry-Academic Cooperation Foundation | Porous nanofiber mesh for three-dimensional cell culture |
US20070009564A1 (en) * | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
PL1909973T3 (pl) | 2005-07-15 | 2019-01-31 | Micell Technologies, Inc. | Polimerowe powłoki zawierające proszek leku o kontrolowanej morfologii |
WO2007011708A2 (en) | 2005-07-15 | 2007-01-25 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
GB0602637D0 (en) * | 2006-02-09 | 2006-03-22 | Glaxo Group Ltd | Novel process |
EP1834651A1 (en) * | 2006-03-15 | 2007-09-19 | Universiteit Gent | Compositions and methods for veterinary vaccination |
US20100119827A1 (en) * | 2006-04-25 | 2010-05-13 | Research Foundation Of The City University Of New York | Polymer submicron particle preparation by surfactant-mediated precipitation |
WO2007127363A2 (en) | 2006-04-26 | 2007-11-08 | Micell Technologies, Inc. | Coatings containing multiple drugs |
WO2008042909A2 (en) | 2006-10-02 | 2008-04-10 | Micell Technologies Inc. | Surgical sutures having increased strength |
EP1913955A1 (en) | 2006-10-19 | 2008-04-23 | Gerhard, Markus | Novel method for treating H.pylori infections |
CN101678388B (zh) * | 2006-10-23 | 2013-12-11 | 米歇尔技术公司 | 用于在涂覆过程中为基底充电的保持器 |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
EP2111184B1 (en) | 2007-01-08 | 2018-07-25 | Micell Technologies, Inc. | Stents having biodegradable layers |
PT2425820E (pt) | 2007-02-11 | 2015-08-04 | Map Pharmaceuticals Inc | Método de administração terapêutica de dhe para permitir o rápido alívio das enxaquecas ao mesmo tempo que minimiza o perfil de efeitos secundários |
US10265407B2 (en) | 2007-02-15 | 2019-04-23 | Yale University | Modular nanodevices for smart adaptable vaccines |
KR101158981B1 (ko) * | 2007-04-17 | 2012-06-21 | 미셀 테크놀로지즈, 인코포레이티드 | 생체분해성 층을 갖는 스텐트 |
WO2008148013A1 (en) * | 2007-05-25 | 2008-12-04 | Micell Technologies, Inc. | Polymer films for medical device coating |
US20100172845A1 (en) * | 2007-05-29 | 2010-07-08 | Board Of Regents Of The University Of Texas System | Compositions and methods for treating mycobacterial infections |
CA2700808C (en) | 2007-09-27 | 2017-11-14 | Immunovaccine Technologies Inc. | Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
US20100209452A1 (en) * | 2007-10-03 | 2010-08-19 | Immunovaccine Technologies, Inc | Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
US20100298928A1 (en) * | 2007-10-19 | 2010-11-25 | Micell Technologies, Inc. | Drug Coated Stents |
US9789233B2 (en) * | 2008-04-17 | 2017-10-17 | Micell Technologies, Inc. | Stents having bioabsorbable layers |
WO2009146523A1 (en) | 2008-06-05 | 2009-12-10 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
CA2730995C (en) | 2008-07-17 | 2016-11-22 | Micell Technologies, Inc. | Drug delivery medical device |
US9510856B2 (en) | 2008-07-17 | 2016-12-06 | Micell Technologies, Inc. | Drug delivery medical device |
US20100111831A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for surface abrasion with frozen particles |
US20100111836A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for therapeutic delivery with frozen particles |
US8551505B2 (en) * | 2008-10-31 | 2013-10-08 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8409376B2 (en) | 2008-10-31 | 2013-04-02 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US9050070B2 (en) * | 2008-10-31 | 2015-06-09 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8545855B2 (en) * | 2008-10-31 | 2013-10-01 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8731840B2 (en) | 2008-10-31 | 2014-05-20 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US9072799B2 (en) * | 2008-10-31 | 2015-07-07 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8721583B2 (en) * | 2008-10-31 | 2014-05-13 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US9060931B2 (en) * | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for delivery of frozen particle adhesives |
US9050317B2 (en) * | 2008-10-31 | 2015-06-09 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8725420B2 (en) * | 2008-10-31 | 2014-05-13 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US20100111857A1 (en) | 2008-10-31 | 2010-05-06 | Boyden Edward S | Compositions and methods for surface abrasion with frozen particles |
US20100111834A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for therapeutic delivery with frozen particles |
US8603496B2 (en) * | 2008-10-31 | 2013-12-10 | The Invention Science Fund I, Llc | Compositions and methods for biological remodeling with frozen particle compositions |
US8603495B2 (en) * | 2008-10-31 | 2013-12-10 | The Invention Science Fund I, Llc | Compositions and methods for biological remodeling with frozen particle compositions |
US20110150765A1 (en) * | 2008-10-31 | 2011-06-23 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Frozen compositions and methods for piercing a substrate |
US9060926B2 (en) * | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8849441B2 (en) | 2008-10-31 | 2014-09-30 | The Invention Science Fund I, Llc | Systems, devices, and methods for making or administering frozen particles |
US8551506B2 (en) * | 2008-10-31 | 2013-10-08 | The Invention Science Fund I, Llc | Compositions and methods for administering compartmentalized frozen particles |
US8731841B2 (en) | 2008-10-31 | 2014-05-20 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8788211B2 (en) * | 2008-10-31 | 2014-07-22 | The Invention Science Fund I, Llc | Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition |
US9060934B2 (en) * | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8563012B2 (en) * | 2008-10-31 | 2013-10-22 | The Invention Science Fund I, Llc | Compositions and methods for administering compartmentalized frozen particles |
US20100111841A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc | Compositions and methods for surface abrasion with frozen particles |
US8793075B2 (en) * | 2008-10-31 | 2014-07-29 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US9072688B2 (en) | 2008-10-31 | 2015-07-07 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8762067B2 (en) | 2008-10-31 | 2014-06-24 | The Invention Science Fund I, Llc | Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data |
US9050251B2 (en) * | 2008-10-31 | 2015-06-09 | The Invention Science Fund I, Llc | Compositions and methods for delivery of frozen particle adhesives |
US20100111835A1 (en) * | 2008-10-31 | 2010-05-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Compositions and methods for therapeutic delivery with frozen particles |
US8834913B2 (en) * | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
CA2756388C (en) * | 2009-03-23 | 2015-10-27 | Micell Technologies, Inc. | Biodegradable polymers with low acidic impurity |
EP2410954A4 (en) * | 2009-03-23 | 2014-03-05 | Micell Technologies Inc | PERIPHERAL STENTS WITH LAYERS |
US20100239635A1 (en) * | 2009-03-23 | 2010-09-23 | Micell Technologies, Inc. | Drug delivery medical device |
JP5464573B2 (ja) * | 2009-03-31 | 2014-04-09 | 独立行政法人産業技術総合研究所 | 中空粒子の製造方法 |
WO2010120552A2 (en) * | 2009-04-01 | 2010-10-21 | Micell Technologies, Inc. | Coated stents |
WO2010121187A2 (en) | 2009-04-17 | 2010-10-21 | Micell Techologies, Inc. | Stents having controlled elution |
US9803060B2 (en) * | 2009-09-10 | 2017-10-31 | Bridgestone Corporation | Compositions and method for making hollow nanoparticles from metal soaps |
EP2531140B1 (en) | 2010-02-02 | 2017-11-01 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
JP2011207988A (ja) * | 2010-03-29 | 2011-10-20 | Sumitomo Chemical Co Ltd | 樹脂用の加工安定化剤、該加工安定化剤を含む樹脂組成物、および樹脂の加工安定性を向上させる方法 |
EP2560576B1 (en) | 2010-04-22 | 2018-07-18 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
EP2593039B1 (en) | 2010-07-16 | 2022-11-30 | Micell Technologies, Inc. | Drug delivery medical device |
US9821051B1 (en) * | 2010-10-28 | 2017-11-21 | Seqirus UK Limited | Reducing hospitalization in elderly influenza vaccine recipients |
MX350838B (es) | 2011-02-11 | 2017-09-18 | Grain Proc Corporation * | Composicion de sal. |
CA2834532A1 (en) | 2011-04-29 | 2012-11-01 | Selecta Biosciences, Inc. | Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses |
US10464100B2 (en) | 2011-05-31 | 2019-11-05 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
CA2841360A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
EP2747777A4 (en) * | 2011-08-25 | 2015-04-29 | Brian Pulliam | ROTAVIRUS PREPARATIONS WITH EXCESSIVE CALCIUMIONES AND HIGH VISCOSITY TO ENSURE VACCINITY OF THE VACCINE AT HIGH TEMPERATURES |
JP6240077B2 (ja) | 2011-10-06 | 2017-11-29 | イムノバクシーン・テクノロジーズ・インコーポレイテッドImmunovaccine Technologies Inc. | Tlr2を活性化するか、またはその活性を増加させるアジュバントを含むリポソーム組成物およびその使用 |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
EP2841098A4 (en) | 2012-04-23 | 2016-03-02 | Allertein Therapeutics Llc | NANOPARTICLES FOR THE TREATMENT OF ALLERGIES |
ES2962574T3 (es) * | 2012-11-06 | 2024-03-19 | Rochal Tech Llc | Administración de agentes biológicamente activos utilizando disolventes volátiles hidrófobos |
EP2967803B1 (en) | 2013-03-12 | 2023-12-27 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
CA2907915C (en) | 2013-04-03 | 2023-03-07 | Allertein Therapeutics, Llc | Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components |
US10357482B2 (en) | 2013-05-03 | 2019-07-23 | Selecta Biosciences, Inc. | Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity |
EP2996629B1 (en) | 2013-05-15 | 2021-09-22 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
KR20240123409A (ko) | 2014-09-07 | 2024-08-13 | 셀렉타 바이오사이언시즈, 인크. | 유전자 편집 항-바이러스 전달 벡터 면역 반응을 약화시키기 위한 방법 및 조성물 |
WO2017005483A1 (en) * | 2015-07-09 | 2017-01-12 | Evonik Röhm Gmbh | Process for preparing poly(glycolide-co-lactide) copolymer microparticles |
JP6959937B2 (ja) | 2015-12-14 | 2021-11-05 | テクニシェ ユニバーシタット ミュンヘン | ヘリコバクターピロリワクチン |
EP3272354A1 (en) | 2016-07-20 | 2018-01-24 | Technische Universität München | Agents and methods for the prevention or treatment of h. pylori infections |
US20180071394A1 (en) * | 2016-08-25 | 2018-03-15 | Selecta Biosciences, Inc. | Polyester polymer matrices for the delivery of allergens |
AU2018236123B2 (en) | 2017-03-11 | 2024-04-18 | Selecta Biosciences, Inc. | Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant |
KR102170146B1 (ko) * | 2019-03-05 | 2020-10-26 | 서울대학교산학협력단 | Pca 공정을 이용한 배양액의 결정화 장치 및 방법 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4038139A (en) * | 1976-07-16 | 1977-07-26 | G. D. Searle & Co., Limited | Cell culture medium |
US4919929A (en) | 1984-02-01 | 1990-04-24 | Stolle Research & Development Corporation | Mammal immunization |
JPS60100516A (ja) | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
US5417986A (en) * | 1984-03-16 | 1995-05-23 | The United States Of America As Represented By The Secretary Of The Army | Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres |
EP0190833B1 (en) | 1985-02-07 | 1991-03-27 | Takeda Chemical Industries, Ltd. | Method for producing microcapsule |
US5075109A (en) * | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
GB8919819D0 (en) * | 1989-09-01 | 1989-10-18 | Coopers Animal Health | Complexes having adjuvant activity |
US5622649A (en) | 1991-06-27 | 1997-04-22 | Emory University | Multiple emulsions and methods of preparation |
ATE165749T1 (de) | 1991-06-27 | 1998-05-15 | Univ Emory | Mehrkomponentemulsionen und verfahren zur deren herstellung |
CH683149A5 (fr) * | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Procédé pour la préparation de microsphères en matériau polymère biodégradable. |
MX9301706A (es) | 1992-04-13 | 1994-05-31 | Oravax Inc | Composicion de vacuna para el tratamiento de la infeccion por helicobacter. |
ES2095001T5 (es) | 1992-12-22 | 2001-03-16 | Univ Cincinnati | Una composicion terapeutica administrable oralmente y su metodo de obtencion. |
US5562909A (en) | 1993-07-12 | 1996-10-08 | Massachusetts Institute Of Technology | Phosphazene polyelectrolytes as immunoadjuvants |
DK0724433T3 (da) | 1993-10-22 | 1999-08-30 | Genentech Inc | Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje |
ATE224184T1 (de) | 1993-10-22 | 2002-10-15 | Genentech Inc | Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe |
US5922253A (en) | 1995-05-18 | 1999-07-13 | Alkermes Controlled Therapeutics, Inc. | Production scale method of forming microparticles |
AR003125A1 (es) * | 1995-06-01 | 1998-07-08 | Astra Ab | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
GB9514285D0 (en) * | 1995-07-13 | 1995-09-13 | Univ Nottingham | Polymeric lamellar substrate particles for drug delivery |
KR0180334B1 (ko) * | 1995-09-21 | 1999-03-20 | 김윤 | 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법 |
US6042820A (en) * | 1996-12-20 | 2000-03-28 | Connaught Laboratories Limited | Biodegradable copolymer containing α-hydroxy acid and α-amino acid units |
US6322810B1 (en) * | 1997-07-14 | 2001-11-27 | Hayat Alkan-Onyuksel | Materials and methods for making improved micelle compositions |
RU2266647C2 (ru) * | 1999-10-26 | 2005-12-27 | Авентис Кропсайенс Гмбх | Гербицидное средство, способ его получения и способ борьбы с вредными растениями |
US6521736B2 (en) * | 2000-09-15 | 2003-02-18 | University Of Massachusetts | Amphiphilic polymeric materials |
-
1998
- 1998-04-14 SE SE9801288A patent/SE9801288D0/xx unknown
-
1999
- 1999-04-09 JP JP2000543160A patent/JP4759134B2/ja not_active Expired - Fee Related
- 1999-04-09 AU AU40662/99A patent/AU765118B2/en not_active Ceased
- 1999-04-09 EP EP99924075A patent/EP1071457B1/en not_active Expired - Lifetime
- 1999-04-09 AT AT99924075T patent/ATE545432T1/de active
- 1999-04-09 US US09/308,435 patent/US6838089B1/en not_active Expired - Fee Related
- 1999-04-09 WO PCT/SE1999/000582 patent/WO1999052550A1/en active IP Right Grant
-
2011
- 2011-01-07 JP JP2011001576A patent/JP2011140491A/ja not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU4066299A (en) | 1999-11-01 |
ATE545432T1 (de) | 2012-03-15 |
EP1071457B1 (en) | 2012-02-15 |
JP2002516822A (ja) | 2002-06-11 |
WO1999052550A1 (en) | 1999-10-21 |
JP4759134B2 (ja) | 2011-08-31 |
AU765118B2 (en) | 2003-09-11 |
EP1071457A1 (en) | 2001-01-31 |
JP2011140491A (ja) | 2011-07-21 |
US6838089B1 (en) | 2005-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9801288D0 (sv) | Vaccine delivery system and metod of production | |
GB2199328B (en) | Use of a 5' untranslated leader sequence of an rna virus to enhance translation | |
Lepage et al. | Purification and characterization of the sea urchin embryo hatching enzyme | |
FI953442A (fi) | Gonadotropiinia sisältäviä pakastekuivattuja pallosia | |
TR200103149T2 (tr) | Virüs ve mikoplazmanın korunması için yöntemler | |
DK0787112T3 (da) | Aerogelholdig sammensætning, fremgangsmåde til dens fremstilling samt dens anvendelse | |
ATE296839T1 (de) | Antikörper zur krebsbehandlung und -diagnose | |
NZ504936A (en) | Simultaneous administration of polynucleotide and delayed release polypeptide encoded by the polynucleotide to enhance an immune response of nucleic acid vaccination | |
AR012089A1 (es) | Un metodo de dos etapas para preparar una composicion detergente en barra que tiene una deposicion aumentada de un agente beneficioso | |
DK0957935T3 (da) | Chlamydia-vacciner og immunogene præparater indeholdende et ydre membran-antigen samt fremgangsmåde til fremstilling deraf | |
DK699488D0 (da) | Magnetiserbare komposit-partikler til biologisk anvendelse og fremgangsmaade til fremstilling af saadanne partikler | |
BR9712556A (pt) | Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno | |
NO20011656D0 (no) | Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser | |
GB2324093A (en) | Helicobacter pylori bacterioferritin | |
BR9407841A (pt) | Processo para aperfeiçoar a ingestão de nutrientes de um animal semelhante a ruminante ou ruminante e preparação veterinária | |
DK1104249T3 (da) | Calciumsensitiv pektinsammensætning | |
DE69614390D1 (de) | Antiwachstumwirksame proteine aus oozyten von rana pipiens | |
ATE223726T1 (de) | Formulierung zur peptidfreisetzung | |
WO2001054707A3 (de) | Veränderung von oberflächenproteomem durch aminopeptidase-inhibitoren | |
DE69429521D1 (de) | Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung | |
AU673344B2 (en) | Vaccines based on streptokinase | |
AU6222796A (en) | Process and apparatus for the magnetic treatment of substancs | |
DE59611353D1 (de) | Transketolase-verwandtes protein | |
Hedlund | Anthrax and anthrax toxin. | |
WO1991000348A3 (de) | Modifizierte vp1/p2a regionen des rhinoviralen systems |